These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2404388)

  • 21. Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.
    Cowley MJ; Hastillo A; Vetrovec GW; Fisher LM; Garrett R; Hess ML
    Circulation; 1983 May; 67(5):1031-8. PubMed ID: 6831667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis.
    MacLennan BA; McMaster A; Webb SW; Khan MM; Adgey AA
    Br Heart J; 1986 Mar; 55(3):231-9. PubMed ID: 3954907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.
    I.S.A.M. Study Group
    N Engl J Med; 1986 Jun; 314(23):1465-71. PubMed ID: 2871492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized double-blind trial of intravenous streptokinase for acute myocardial infarction.
    Schreiber TL; Miller DH; Silvasi DA; Moses JW; Borer JS
    Am J Cardiol; 1986 Jul; 58(1):47-52. PubMed ID: 3524182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.
    Goa KL; Henwood JM; Stolz JF; Langley MS; Clissold SP
    Drugs; 1990 May; 39(5):693-719. PubMed ID: 2191849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.
    Anderson JL; Sorensen SG; Moreno FL; Hackworthy RA; Browne KF; Dale HT; Leya F; Dangoisse V; Eckerson HW; Marder VJ
    Circulation; 1991 Jan; 83(1):126-40. PubMed ID: 1984877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.
    Battershill PE; Benfield P; Goa KL
    Drugs Aging; 1994 Jan; 4(1):63-86. PubMed ID: 8130384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term infarct vessel patency with aspirin and dipyridamole started 24 to 36 hours after intravenous streptokinase.
    Hays LJ; Beller GA; Moore CA; Burwell LR; Craddock GB; Gascho JA; Smucker ML; Tedesco C; Nygaard TW
    Am Heart J; 1988 Apr; 115(4):717-21. PubMed ID: 3354400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
    J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of early high-dose streptokinase intravenously on left ventricular function in acute myocardial infarction.
    Bassand JP; Faivre R; Becque O; Habert C; Schuffenecker M; Petiteau PY; Cardot JC; Verdenet J; LaRoze M; Maurat JP
    Am J Cardiol; 1987 Sep; 60(7):435-9. PubMed ID: 3307367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction.
    Col JJ; Col-De Beys CM; Renkin JP; Lavenne-Pardonge EM; Bachy JL; Moriau MH
    Am J Cardiol; 1989 May; 63(17):1185-92. PubMed ID: 2653017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous streptokinase in acute myocardial infarction at the community hospital: a six-year experience.
    Vogel JH; Setty RK; Coughlin BJ; Avolio RM; McFadden RB
    Am J Cardiol; 1988 Dec; 62(18):25K-27K. PubMed ID: 3195495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
    Frostfeldt G; Ahlberg G; Gustafsson G; Helmius G; Lindahl B; Nygren A; Siegbahn A; Swahn E; Venge P; Wallentin L
    J Am Coll Cardiol; 1999 Mar; 33(3):627-33. PubMed ID: 10080461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study).
    Taylor GJ; Moses HW; Koester D; Colliver JA; Katholi RE; Dove JT; Woodruff RC; Mikell FL; Becker LC; Sheehan FH
    Am J Cardiol; 1993 Nov; 72(14):1010-4. PubMed ID: 8213579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction.
    Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U
    Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled trial of intravenous streptokinase in evolving acute myocardial infarction.
    Olson HG; Butman SM; Piters KM; Gardin JM; Lyons KP; Jones L; Chilazi G; Kumar KL; Colombo A
    Am Heart J; 1986 Jun; 111(6):1021-9. PubMed ID: 3521245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose intravenous streptokinase in acute myocardial infarction.
    Neuhaus KL; Tebbe U; Sauer G; Kreuzer H; Köstering H
    Clin Cardiol; 1983 Sep; 6(9):426-34. PubMed ID: 6627771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.